DOI:
10.37988/1811-153X_2022_2_94Potential COVID-19 complications in oral cavity and maxillofacial area
Downloads
Abstract
At the moment, COVID-19 is one of the most urgent pathologies, affecting the practice of doctors of various specialties. Despite this, very little is known about all the pathogenetic mechanisms of the development of a local and systemic response, and, accordingly, about all forms of manifestation of COVID-19. This article discusses the clinical manifestation of COVID-19 complications in oral cavity and maxillofacial localisation based on data from recent publications. Oral manifestations included variable mucosal lesions consistent with diagnoses such as aphthous stomatitis, herpetiform lesions, candidiasis, vasculitis, mucositis, necrotizing periodontal disease, angular cheilitis, Melkerson-Rosenthal syndrome. One of the important trends is the growth of concomitant fungal infections caused by Mucor, Rhizomucor and Aspergillus. Most often, especially in foreign sources, there was a description of rhino-orbito-cerebral acute invasive fungal rhinosinusitis, which is a potentially life-threatening fungal infection. The development of such a complication of COVID-19 can be associated with several factors, such as the nature of the immune response when the organism is damaged by the SARS-CoV-2 and the active prescription of antibiotic therapy. In the presence of an initial lesion in the sinonasal localization, the orbit is quickly involved in the pathological process, and then invasion of the cavernous sinus becomes possible. Intracranial complications include leptomeningitis or cerebritis and intracranial abscess. The nature of the changes is similar to the manifestations in sinusitis developing in connection with red bone marrow transplantation, respectively, we can assume a similar level of immunosuppression in the defeat of COVID-19. Another important distinguishing feature of the complications of coronavirus infection is the occurrence of a generalized prothrombotic state with subsequent microvascular and macrovascular thromboembolism. The most common reports are pulmonary embolism, deep vein thrombosis, cerebral infarction, and cerebral venous sinus thrombosis. In the maxillofacial localization, manifestations are possible in the form of necrotic changes in the facial bones associated with arterial thrombosis. Thus, based on the analyzed scientific publications, COVID-19 is a multisystem disease with the development of characteristic complications in the oral cavity and maxillofacial localization.Key words:
COVID-19, sinusitis, thrombosisFor Citation
[1]
Antonova I.N., Grygoriants A.P., Kalakutskiy N.V., Petropavlovskaya O.Yu., Grygoriants A.A., Samodurov A.S. Potential COVID-19 complications in oral cavity and maxillofacial area. Clinical Dentistry (Russia). 2022; 25 (2): 94—99. DOI: 10.37988/1811-153X_2022_2_94
References
- Morens D.M., Daszak P., Markel H., Taubenberger J.K. Pandemic COVID-19 joins history‘s pandemic legion. — mBio. — 2020, 11 (3): e00812—20. PMID: 32471830
- Liu Y.C., Kuo R.L., Shih S.R. COVID-19: The first documented coronavirus pandemic in history. — Biomed J. — 2020, 43 (4): 328—333. PMID: 32387617
- Salian V.S., Wright J.A., Vedell P.T., Nair S., Li C., Kandimalla M., Tang X., Carmona Porquera E.M., Kalari K.R., Kandimalla K.K. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol Pharm. — 2021, 18 (3): 754—771. PMID: 33464914
- Gu J., Han B., Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. — Gastroenterology. — 2020, 158 (6): 1518—1519. PMID: 32142785
- El-Anwar M.W., Elzayat S., Fouad Y.A. ENT manifestation in COVID-19 patients. — Auris Nasus Larynx. — 2020, 47 (4): 559—564. PMID: 32586739
- Özçelik Korkmaz M., Eğilmez O.K., Özçelik M.A., Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. — Eur Arch Otorhinolaryngol. — 2021, 278 (5): 1675—1685. PMID: 33011957
- Makedonova Yu.A., Poroisky S.V., Gavrikova L.M., Afanaseva O.Y. Manif estat ion of the oral mucosa diseases in patients with COVID-19. — Vestnik VSMU. — 2021, 1 (77): 110—115 (In Russ.). eLIBRARY ID: 45153499
- Kolchanova N., Manak T., Okulich V. The state of the biological system of the oral cavity in patients after COVID-19. — Sovremennaya stomatologiya. 2021, 1 (82): 54—58 (In Russ.). eLIBRARY ID: 44930163
- Vaira L.A., Salzano G., Deiana G., De Riu G. Anosmia and ageusia: Common findings in COVID-19 patients. — Laryngoscope. — 2020, 130 (7): 1787. PMID: 32237238
- Amorim Dos Santos J., Normando A.G.C., Carvalho da Silva R.L., De Paula R.M., Cembranel A.C., Santos-Silva A.R., Guerra E.N.S. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? — Int J Infect Dis. — 2020, 97: 326—328. PMID: 32526392
- Iranmanesh B., Khalili M., Amiri R., Zartab H., Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. — Dermatol Ther. — 2021, 34 (1): e14578. PMID: 33236823
- Sinadinos A., Shelswell J. Oral ulceration and blistering in patients with COVID-19. — Evid Based Dent. — 2020, 21 (2): 49. PMID: 32591655
- Gavrikova L.M., Makedonova Y.U.A., Dyachenko S.V. Assessment of dental status of patients with COVID-19. — Medical and pharmaceutical journal Pulse. — 2021, 10: 50—55 (In Russ.). eLIBRARY ID: 47577774
- Al-Khatib A. Oral manifestations in COVID-19 patients. — Oral Dis. — 2021, 27 Suppl 3: 779—780. PMID: 32521067
- Wadia R. COVID-19 — oral manifestations. — Br Dent J. — 2020, 229 (10): 669. PMID: 33247257
- Corchuelo J., Ulloa F.C. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. — Int J Infect Dis. — 2020, 100: 154—157. PMID: 32882435
- Borisova E.G., Mashkova N.G., Pototskaya A.V. Manifestation of dental pathology after a possible coronaviral infection. — Medical and pharmaceutical journal Pulse. — 2021, 12: 13—20 (In Russ.). eLIBRARY ID: 47573943
- Patel J., Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID-19. — Oral Dis. — 2021, 27 Suppl 3: 768—769. PMID: 32506662
- Rawson T.M., Moore L.S.P., Zhu N., Ranganathan N., Skolimowska K., Gilchrist M., Satta G., Cooke G., Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. — Clin Infect Dis. — 2020, 71 (9): 2459—2468. PMID: 32358954
- Ripa M., Galli L., Poli A., Oltolini C., Spagnuolo V., Mastrangelo A., Muccini C., Monti G., De Luca G., Landoni G., Dagna L., Clementi M., Rovere Querini P., Ciceri F., Tresoldi M., Lazzarin A., Zangrillo A., Scarpellini P., Castagna A., COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. — Clin Microbiol Infect. — 2021, 27 (3): 451—457. PMID: 33223114
- Belotserkovskaia Y.G., Romanovskikh A.G., Smirnov I.P. COVID-19: a respiratory infection caused by new coronavirus: new data on epidemiology, clinical course, and patients management. — Consilium Medicum. — 2020, 3: 12—20 (In Russ.). eLIBRARY ID: 42745698
- Duryagina L.Kh., Sataeva T.P., Degtyareva L.A., Postnikova O.N., Dubrovina-Parus T.A. Candidiasis lesions of the oral mucosa in patients with COVID-19: tactics of patient management, therapy correction. — Crimean Journal of Internal Diseases. — 2021, 3: 40—43 (In Russ.). eLIBRARY ID: 47190240
- Seaton R.A., Gibbons C.L., Cooper L., Malcolm W., McKinney R., Dundas S., Griffith D., Jeffreys D., et al. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. — J Infect. — 2020, 81 (6): 952—960. PMID: 32987097
- Bhattacharyya A., Sarma P., Kaur H., Kumar S., Bhattacharyya J., Prajapat M., Prakash A., Sharma S., Reddy D.H., Thota P., Bansal S., Gautam B.S., Medhi B. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. — Indian J Pharmacol. — 2021, 53 (6): 499—510. PMID: 34975140
- Ashour M.M., Abdelaziz T.T., Ashour D.M., Askoura A., Saleh M.I., Mahmoud M.S. Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: A case series and a review of literature. — J Neuroradiol. — 2021, 48 (5): 319—324. PMID: 34087330
- Song G., Liang G., Liu W. Fungal co-infections associated with global COVID-19 pandemic: A clinical and diagnostic perspective from China. — Mycopathologia. — 2020, 185 (4): 599—606. PMID: 32737747
- Subramani M., Shankaran S. Bacterial sinusitis in the COVID-19 era: A reminder for antibiotic stewardship. — Cureus. — 2021, 13 (11): e19453. PMID: 34926027
- El-Kholy N.A., El-Fattah A.M.A., Khafagy Y.W. Invasive fungal sinusitis in post COVID-19 patients: A new clinical entity. — Laryngoscope. 2021, 131 (12): 2652—2658. PMID: 34009676
- Mehta S., Pandey A. Rhino-orbital mucormycosis associated with COVID-19. — Cureus. — 2020, 12 (9): e10726. PMID: 33145132
- Manchanda S., Semalti K., Bhalla A.S., Thakar A., Sikka K., Verma H. Revisiting rhino-orbito-cerebral acute invasive fungal sinusitis in the era of COVID-19: pictorial review. — Emerg Radiol. — 2021, 28 (6): 1063—1072. PMID: 34463864
- Thajeb P., Thajeb T., Dai D. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. — Scand J Infect Dis. — 2004, 36 (9): 643—8. PMID: 15370650
- Speth M.M., Singer-Cornelius T., Oberle M., Gengler I., Brockmeier S.J., Sedaghat A.R. Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing, and associated characteristics. — Otolaryngol Head Neck Surg. — 2020, 163 (1): 114—120. PMID: 32423357
- Brondfield S., Kaplan L., Dhaliwal G. Palatal mucormycosis. — J Gen Intern Med. — 2018, 33 (10): 1815. PMID: 30088205
- Pai V., Sansi R., Kharche R., Bandili S.C., Pai B. Rhino-orbito-cerebral mucormycosis: Pictorial review. — Insights Imaging. — 2021, 12: 167. PMID: 34786029
- Garg R., Bharangar S., Gupta S., Bhardwaj S. Post COVID-19 infection presenting as rhino-orbital mycosis. — Indian J Otolaryngol Head Neck Surg. — 2021, 1—8 (online ahead of print). PMID: 34307112
- Wang H., Song J., Pan L., Yao Y., Deng Y.K., Wang Z.C., Liao B., Ma J., He C., Zeng M., Liu Z. The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19. — J Allergy Clin Immunol Pract. — 2020, 8 (10): 3597—3599.e2. PMID: 32980581
- Mohammadi F., Badri M., Safari S., Hemmat N. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update. — BMC Infect Dis. — 2021, 21 (1): 906. PMID: 34479495
- Talmi Y.P., Goldschmied-Reouven A., Bakon M., Barshack I., Wolf M., Horowitz Z., Berkowicz M., Keller N., Kronenberg J. Rhino-orbital and rhino-orbito-cerebral mucormycosis. — Otolaryngol Head Neck Surg. — 2002, 127 (1): 22—31. PMID: 12161726
- Makovskaya N.I., Vasilyev A.V. Features of the work of a dentist and maxillofacial surgeon in a pandemic of a new coronavirus infection (COVID-19). World experience and own practice. — Parodontologiya. — 2020, 3: 185—188 (In Russ.). eLIBRARY ID: 43865431
- Drozd-Sokolowska J.E., Sokolowski J., Wiktor-Jedrzejczak W., Niemczyk K. Sinusitis in patients undergoing allogeneic bone marrow transplantation — a review. — Braz J Otorhinolaryngol. — 2017, 83 (1): 105—111. PMID: 27184506
- Shires C.B., Klug T., Dryden S., Ford J. Unusual cause of acute sinusitis and orbital abscess in COVID-19 positive patient: Case report. — Int J Surg Case Rep. — 2021, 79: 164—168. PMID: 33477076
- de Roquetaillade C., Chousterman B.G. et al. Unusual arterial thrombotic events in COVID-19 patients. — Int J Cardiol. — 2021, 323: 281—284. PMID: 32918938
- Gómez-Mesa J.E., Galindo-Coral S., Montes M.C., Muñoz Martin A.J. Thrombosis and coagulopathy in COVID-19. — Curr Probl Cardiol. 2021, 46 (3): 100742. PMID: 33243440
- Long B., Bridwell R., Gottlieb M. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. — Am J Emerg Med. — 2021, 49: 58—61. PMID: 34062319
- Chan N.C., Weitz J.I. COVID-19 coagulopathy, thrombosis, and bleeding. — Blood. — 2020, 136 (4): 381—383. PMID: 32702124
- Mei H., Luo L., Hu Y. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. — J Hematol Oncol. — 2020, 13 (1): 161. PMID: 33261634
- Wool G.D., Miller J.L. The impact of COVID-19 disease on platelets and coagulation. — Pathobiology. — 2021, 88 (1): 15—27. PMID: 33049751
- Kashi M., Jacquin A., Dakhil B., Zaimi R., Mahé E., Tella E., Bagan P. Severe arterial thrombosis associated with COVID-19 infection. — Thromb Res. — 2020, 192: 75—77. PMID: 32425264
- Katneni U.K., Alexaki A., et al. Coagulopathy and thrombosis as a result of severe COVID-19 infection: A microvascular focus. Thromb Haemost. — 2020, 120 (12): 1668—1679. PMID: 32838472
- Libby P., Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. — 2020, 41 (32): 3038—3044. PMID: 32882706
- Sedlaczek O., Wagner W., Dempfle C.E. [COVID-19-induced coagulopathy and thrombosis manifestations]. — Radiologe. — 2021, 61 (10): 909—914 (In German). PMID: 34559248
- Leisman D.E., Deutschman C.S., Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. — Intensive Care Med. — 2020, 46 (6): 1105—1108. PMID: 32347323
- Costanzo L., Failla G., Antignani P.L., Fareed J., Gu Y., Pitha J., Aluigi L., Karplus T., Mansilha A. The vascular side of COVID-19 disease. Position paper of the International Union of Angiology. — Int Angiol. 2020, 39 (6): 445—451. PMID: 32892615
- Karimzadeh S., Dong V., Hassan O.G., Raut A., Fouda A., Parrill A., Eaton K., Huy N.T. COVID-19-induced coagulopathy and observed benefits with anticoagulation. — Transfus Apher Sci. — 2020, 59 (6): 102906. PMID: 32778522
- Ahmed O., Aladham Y., Mahmood S., Abdelnaby M.M. Complicated sinusitis with sphenopalatine artery thrombosis in a COVID-19 patient: a case report. — J Surg Case Rep. — 2021, 2021 (3): rjab010. PMID: 33732419
Downloads
Received
March 29, 2022
Published on
June 1, 2022